Policy & oversight
CMS Finalizes Rule Letting Top Organ Procurement Organizations Compete for New Service Areas
A federal rule published October 30 gives high-performing, Medicare-certified organ recovery organizations the ability to bid for territories where peer organizations have failed, while sharpening the tools CMS can use to remove bad actors.
By the Goodsurance editorial teamOctober 31, 2026
The Centers for Medicare and Medicaid Services finalized a rule on October 30, 2026, updating oversight standards for the organ procurement organizations (OPOs) that CMS certifies under Medicare law. OPOs coordinate organ recovery from deceased donors and arrange placement with transplant centers. Each OPO serves a defined geographic territory, and those territories have historically been fixed assignments.
The final rule changes the competitive landscape. High-performing OPOs may now apply to take over a neighboring service area when the assigned organization there underperforms or loses its certification. CMS says the change creates accountability by allowing better-run organizations to expand into struggling territories rather than leaving those areas without strong coverage.
A new federal rule lets top organ recovery organizations compete for underperforming territories and gives CMS faster tools to shut down those that break the rules.
The rule also defines what constitutes unsound medical practices with greater precision, giving CMS clearer authority to begin emergency decertification of a noncompliant OPO without waiting for a full recertification cycle. An OPO medical director must now hold an active license in at least one state or territory the organization serves.
On service-area transitions, outgoing OPOs must cooperate with incoming replacements, and incoming organizations must file progress reports so that organ recovery operations remain uninterrupted during handoffs. OPOs must also document the disposition of every organ sent for research, including pancreata used for islet cell research, a change CMS says will make performance scores reflect organs actually transplanted rather than those counted only in research pipelines.
For Medicare beneficiaries on transplant waiting lists, the rule means tighter federal oversight of the organizations that recover the organs they depend on.
In plain words
CMS runs Medicare. It also certifies special organizations that collect donated organs and find patients who need them. These groups are called OPOs.
CMS published a new rule on October 30, 2026. The rule makes several changes.
First, a well-run OPO can now try to take over an area where another OPO is doing a poor job. That was not allowed before.
Second, CMS can act faster to shut down an OPO that breaks the rules.
Third, the medical leader of an OPO must now have a medical license in a state that OPO serves.
Fourth, when one OPO hands off its area to another, there are clearer steps to keep organ recovery going without gaps.
If you are on a transplant waiting list and have Medicare, this rule means the government is watching more closely over the organizations that find organs for people who need them.
Understand the basics first
Source: CMS
Read at the source →